Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Feb 26, 2026 10:43:35 AM EST

129.90USD-0.953%(-1.25)4,742

129.23Bid 129.72Ask 0.49Spread

Pre-market

0.00USD-100.000%(-131.15)0

After-hours

Feb 24, 2026 4:00:30 PM EST

130.96USD+0.053%(+0.07)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

13.17B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

May 6, 2026 (68d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,611,927

Avg. Vol. 30 Day

1,223,088

Employees

470

Market Cap

13,165,679,076

Shares Out.

100,363,463

On/Off Exchange

62%/38%

6 Month Beta

0.84

1 Year Beta

0.85

2 Year Beta

0.79

3 Year Beta

0.72

52 Week Low

84.23

52 Week High

160.18

SMA50

137.89

SMA200

136.13

1 Week

+2.18%

1 Month

-2.48%

3 Month

-8.60%

6 Month

-2.10%

1 Year

+13.18%

2 Year

-3.25%

5 Year

+22.82%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $129.90, and today's volume is 4,742. NBIX is down -0.953% today. The 30 day average volume is 1,223,088. NBIX market cap is 13.17B with 100,363,463 shares outstanding.